Diprivan® (propofol) Injectable Emulsion, USP

Our Commitment Goes On And On

December 21, 2012

Effective immediately, Fresenius Kabi USA will no longer include vented spikes or stopcocks with the Diprivan 50 mL and 100 mL single patient infusion vials. Implementing this change will allow more efficient operations and is consistent with the current Propofol 50 mL and 100 mL package design.

We expect this to be a seamless transition with no impact to product distribution or availability.

Fresenius Kabi USA understands that a continuous supply of propofol 1% is crucial to the care of patients. Please be assured that our commitment and responsiveness to this critically needed drug is of the utmost importance to our company.

For clinical or technical questions regarding our products, please call Medical Affairs at 1-800-551-7176 between the hours of 8 a.m. – 5 p.m. Central Standard Time.

Thank you for your continued patience, cooperation and support.